Gingivax LLC News - Profile and Newsroom at Send2Press Newswire

Gingivax LLC Newsroom - Profile and News Archive

Gingivax LLC is a new company centered around the benefits of the oral microbiome, and it is investigating oral bacteria as a potential source of new adjuvants. Molecules extracted from these bacteria, which can activate crucial Th17 cells, could be added to vaccines to increase their efficacy.

Engage with Gingivax LLC

Follow:

Press Releases from Gingivax LLC :

Mouth bacteria could make stronger vaccines

Jun 3, 2021 7:00 AM EDT

HAMPTON, N.J., June 3, 2021 (SEND2PRESS NEWSWIRE) — Three researchers have published a groundbreaking paper on the importance of oral bacteria in the fight against infectious diseases like influenza, HIV, and COVID-19, Gingivax LLC announced today.